Recombinant HIV-2 Antigens

Human Immunodeficiency Virus type 2 (HIV-2) is less prevalent than HIV-1 and occurs predominantly in West Africa, but remains clinically important due to its distinct epidemiology and diagnostic requirements. Our recombinant HIV-2 antigens support serological research, assay development, and diagnostic applications.

Our portfolio includes gp105, gp140, and two variants of gp36, covering important HIV-2 envelope antigens. Produced under controlled conditions, these recombinant proteins provide high purity, excellent consistency, and dependable performance across ELISA and other immunoassay platforms.